本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CERo Therapeutics Holdings, Inc.

9.26
-0.2000-2.11%
盘后9.22-0.0400-0.43%16:48 EDT
成交量:5.68万
成交额:53.06万
市值:477.91万
市盈率:0.00
高:9.57
开:9.35
低:9.22
收:9.46
数据加载中...
2024/07/03

SEC问询函

Form CORRESP - Correspondence
2024/06/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/06/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/05

SEC问询函

Form CORRESP - Correspondence
2024/05/17

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/05/04

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/29

SEC问询函

Form CORRESP - Correspondence
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/04/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/22

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]